Financial Toxicity in Cancer Patients
Public ClinicalTrials.gov record NCT04592250. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Financial Toxicity in Diverse Cancer Populations and Care Settings
Study identification
- NCT ID
- NCT04592250
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Enrollment
- 625 participants
Conditions and interventions
Interventions
- Survey Administration Other
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 11, 2020
- Primary completion
- Aug 31, 2028
- Completion
- Aug 31, 2028
- Last update posted
- Apr 15, 2026
2020 – 2028
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| DCH Regional Medical Center | Tuscaloosa | Alabama | 35401 | — |
| Scripps - MD Anderson Cancer Center | La Jolla | California | 92037 | — |
| Baptist- MD Anderson Cancer Center | Jacksonville | Florida | 32207 | — |
| The Queen's Medical Center | Honolulu | Hawaii | 96813 | — |
| Lyndon Baines Johnson General Hospital | Houston | Texas | 77026 | — |
| M D Anderson Cancer Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04592250, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2026 · Synced Apr 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04592250 live on ClinicalTrials.gov.